Fosmo Med
Fosmo Med is a private medical device company that has developed the Maji and Maji2 Forward Osmosis IV hydration systems, which ship without water and reconstitute sterile IV solutions from local water at the point of care, targeting disaster relief NGOs, government health agencies, and military medical buyers.
- Company typePrivate
- Founded2015
- HeadquartersSan Mateo, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Fosmo Med does
Fosmo Med is a private medical device company founded around 2012 and headquartered in San Mateo, California, developing a Forward Osmosis (FO) based field hydration system for intravenous use. The company's core products — Maji and the second-generation Maji2 — are patent-pending medical devices that are shipped without water and convert any available water source (excluding seawater and urine) at the point of care into a sterile IV solution, without requiring electrical power. The underlying FO technology, originally researched by NASA in the 1970s, uses a salt-driven osmotic gradient across a membrane to reconstitute solutions compatible with sodium chloride, dextrose, potassium chloride, or magnesium IV formulations.
The product is engineered for austere deployment: a 1-liter Maji bag weighs approximately 3 ounces versus roughly 2.3 pounds for a standard saline bag, and is built from DEHP-free materials with a single-use anti-reuse feature. Reported performance claims include up to 80% reduction in shipping cost ($14.92/liter for Maji vs $50.71/liter for standard saline on a San Francisco-to-Guinea comparison) and roughly 3x more units shipped per unit of space.
Fosmo Med's go-to-market targets three verticals — disaster relief NGOs (referenced customers include Jordan International Aid), government health agencies, and military medical units — via an enterprise field sales motion, with an asset-light distribution plan to partner with established IV manufacturers and distributors. Revenue mechanics are hardware sales at unit pricing (a 14-bag box of Maji is quoted at $209 versus $710 for the standard IV equivalent); however, no revenue, paying customers beyond pilot/charitable deployments, regulatory clearances, or certifications are disclosed, and the company is publicly seeking investors to bring the device to market. The leadership team is led by serial entrepreneur Ben Park (CEO/Founder; prior exits Scentric to Broadcom and Infrant Technologies to Netgear), with Diane Cooper as Director of Clinical Affairs.
Fosmo Med firmographics
Firmographics- Name
- Fosmo Med
- Legal name
- Fosmo Med
- Website
- https://fosmomed.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Fosmo Med is a private medical device company that has developed the Maji and Maji2 Forward Osmosis IV hydration systems, which ship without water and reconstitute sterile IV solutions from local water at the point of care, targeting disaster relief NGOs, government health agencies, and military medical buyers.
- Ownership category
- akta.pro rank
Where Fosmo Med is headquartered
LocationHeadquarters
- HQ city
- San Mateo
- HQ country
- United States
- HQ region
- North America
Markets served
Fosmo Med business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device Sales: Fosmo Med generates revenue through the sale of their Maji IV hydration products. The company plans to partner with existing manufacturers and distributors to serve the current IV solution market.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Maji IV Bags - 1 Liter Size |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Fosmo Med product offering
Product offeringCore offering
Fosmo Med manufactures and sells Maji, a Forward Osmosis-based field hydration system for IV use. The product is shipped without water and uses any available water source at the point of care to create a sterile IV solution without requiring power. A second-generation version, Maji2, extends the same FO-based product line. The systems target disaster relief, military, and government health agency buyers in lieu of heavy, power-dependent traditional saline IV bags.
Product overview
Fosmo Med offers a product line centered on Maji and Maji2, field hydration systems for intravenous use based on Forward Osmosis (FO) technology. These medical devices are shipped without water and convert any water source at the point of care into sterile IV solutions without requiring power. Maji is the first-generation product designed for disaster relief, civilian, and military applications. Maji2 represents the next generation in the product line.
Differentiator
Problem solved
Functional benefit
Brands
- Maji: First-generation revolutionary field hydration system for intravenous use based on Forward Osmosis (FO) technology. Shipped without water, uses any water source at site of care to create sterile solution without power requirement. Product name means water in Swahili.
- Maji2
Products and services
- Maji First-generation revolutionary field hydration system for intravenous use based on Forward Osmosis (FO) technology. Shipped without water, it uses any clean or contaminated water source (except seawater and urine) at the point of care to create a sterile IV solution without requiring any power, targeting disaster relief, civilian, and military medical use.
- Maji2 Second-generation Forward Osmosis-based field hydration system building on the original Maji product, listed on the Fosmo Med website as the continuation of the Maji product line for field IV hydration.
Quantifiable outcome
- 2.2 million children die annually from dehydration; Fosmo Med's solution could save hundreds of thousands of lives annually
- +3 more outcomes
Companies that use Fosmo Med
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Fosmo Med technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Fosmo Med partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PhilipscorePhilips selected Fosmo Med's revolutionary intravenous solution as the winner of the Philips Innovation Fellows Competition. The competition win provided recognition and visibility for the company's technology and products. Philips America CEO also interviewed Fosmo Med CEO Ben Park, indicating ongoing engagement and support from Philips.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Fosmo Med competitors and assessment
Company assessmentDirect peers
- Baxter International: Global leader in IV solutions, IV bags, and sterile fluids for hospitals and clinical settings. Directly competes with Fosmo Med's IV hydration business in the established medical IV market.
- Fresenius Kabi: Global medical device and clinical nutrition company with a significant IV solutions portfolio. Competes head-to-head with Fosmo Med in the IV and infusion therapy space.
- Hospira (Pfizer): Pre-Pfizer-acquisition leader in sterile injectable pharmaceuticals and IV solutions. Closely comparable legacy player in the IV solutions market that Fosmo Med targets.
- ICU Medical: Specializes in IV therapy products including IV bags, infusion sets, and needle-free connectors. Operates in the same IV medical device category as Fosmo Med.
- Terumo: Global medical device company with IV and infusion therapy products. Comparable in product category though with a broader medical device portfolio than Fosmo Med.
- B. Braun Melsungen: Major manufacturer of IV solutions and infusion medical devices with strong global distribution across hospitals. Directly comparable to Fosmo Med in the IV solutions category.
Broad incumbents
- Smiths Medical: Medical device manufacturer with IV infusion pumps and related consumables. Overlaps with Fosmo Med's IV delivery category though the company primarily serves established hospital-based customers.
- Cardinal Health: Major medical distributor and healthcare services company. Comparable as an institutional channel for IV-related and emergency medical supplies across U.S. hospitals and government health agencies.
- Teleflex: Diversified medical device company with vascular access and infusion therapy products. Overlaps with Fosmo Med in IV-related devices but operates broadly across hospital equipment.
- Medline Industries: Largest privately held medical supplies manufacturer and distributor. Comparable as a distribution channel for medical supplies and IV consumables, though with a much broader portfolio than Fosmo Med.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Fosmo Med social profiles
Digital presenceFosmo Med financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fosmo Med leadership team
Management profileNumber of profiles
Profiles2 records
Fosmo Med funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fosmo Med M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fosmo Med
What does Fosmo Med do?
Fosmo Med manufactures and sells Maji, a Forward Osmosis-based field hydration system for IV use. The product is shipped without water and uses any available water source at the point of care to create a sterile IV solution without requiring power. A second-generation version, Maji2, extends the same FO-based product line. The systems target disaster relief, military, and government health agency buyers in lieu of heavy, power-dependent traditional saline IV bags.
Is Fosmo Med a public or private company?
Fosmo Med is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Fosmo Med founded?
Fosmo Med was founded in 2015. It employs 1 to 10 people.
Where is Fosmo Med based?
Fosmo Med is headquartered in San Mateo, United States, in the North America region.
How does Fosmo Med make money?
One revenue line is on record: medical Device Sales.
Who are Fosmo Med's main competitors?
Direct peers on record are Baxter International, Fresenius Kabi, Hospira (Pfizer), ICU Medical, Terumo and B. Braun Melsungen. Broad incumbents are Smiths Medical, Cardinal Health, Teleflex and Medline Industries.
Does Fosmo Med have an API?
No public API is recorded for Fosmo Med.